Revolutionizing Sickle Cell Disease Treatment: Unveiling CRISPR and Lentiviral Therapies—Navigating Complexities in Access, Equity, and Global Health Dynamics.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Works matching IS 26348535 AND DT 2024 AND VI 18
Results: 7
1
2
Biochemical and Functional Characterization of Plasma Derived Human Celestrase 1.
- Published in:
- Plasmatology, 2024, v. 18, p. 1, doi. 10.1177/26348535231225317
- By:
- Publication type:
- Article
3
Platelet Transfusion Refractoriness.
- Published in:
- Plasmatology, 2024, v. 18, p. 1, doi. 10.1177/26348535241284460
- By:
- Publication type:
- Article
4
Complexity of Platelet-Rich Plasma: Mechanism of Action, Growth Factor Utilization and Variation in Preparation.
- Published in:
- Plasmatology, 2024, v. 18, p. 1, doi. 10.1177/26348535241277625
- By:
- Publication type:
- Article
5
Insights into the Purification of C1-esterase Inhibitor from Human Plasma.
- Published in:
- Plasmatology, 2024, v. 18, p. 1, doi. 10.1177/26348535241236299
- By:
- Publication type:
- Article
6
Effects of Tariff on the Management of Blood Products in Fars Province Hospitals.
- Published in:
- Plasmatology, 2024, v. 18, p. 1, doi. 10.1177/26348535231225315
- By:
- Publication type:
- Article
7
Management of a Young Patient With High-risk Multiple Myeloma Complicated by Acquired von Willebrand Syndrome: A Diagnostic and Therapeutic Emergency.
- Published in:
- Plasmatology, 2024, v. 18, p. 1, doi. 10.1177/26348535231222994
- By:
- Publication type:
- Article